Eli Lilly and Company (LLY)
NYSE: LLY · Real-Time Price · USD
883.96
-33.69 (-3.67%)
At close: Apr 24, 2026, 4:00 PM EDT
885.49
+1.53 (0.17%)
Pre-market: Apr 27, 2026, 5:02 AM EDT
Eli Lilly Employees
Eli Lilly and Company had 50,000 employees as of December 31, 2025. The number of employees increased by 3,000 or 6.38% compared to the previous year.
Employees
50,000
Change (1Y)
3,000
Growth (1Y)
6.38%
Revenue / Employee
$1,303,580
Profits / Employee
$412,800
Market Cap
790.98B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 50,000 | 3,000 | 6.38% |
| Dec 31, 2024 | 47,000 | 4,000 | 9.30% |
| Dec 31, 2023 | 43,000 | 4,000 | 10.26% |
| Dec 31, 2022 | 39,000 | 4,000 | 11.43% |
| Dec 31, 2021 | 35,000 | 0 | - |
| Dec 31, 2020 | 35,000 | 1,375 | 4.09% |
| Dec 31, 2019 | 33,625 | -5,055 | -13.07% |
| Dec 31, 2018 | 38,680 | -1,975 | -4.86% |
| Dec 31, 2017 | 40,655 | -1,320 | -3.14% |
| Dec 31, 2016 | 41,975 | 700 | 1.70% |
| Dec 31, 2015 | 41,275 | 2,140 | 5.47% |
| Dec 31, 2014 | 39,135 | 1,210 | 3.19% |
| Dec 31, 2013 | 37,925 | -425 | -1.11% |
| Dec 31, 2012 | 38,350 | 270 | 0.71% |
| Dec 31, 2011 | 38,080 | -270 | -0.70% |
| Dec 31, 2010 | 38,350 | -2,010 | -4.98% |
| Dec 31, 2009 | 40,360 | -140 | -0.35% |
| Dec 31, 2008 | 40,500 | -100 | -0.25% |
| Dec 31, 2007 | 40,600 | -900 | -2.17% |
| Dec 31, 2006 | 41,500 | -1,100 | -2.58% |
| Dec 31, 2005 | 42,600 | -1,900 | -4.27% |
| Dec 31, 2004 | 44,500 | -1,600 | -3.47% |
| Dec 31, 2003 | 46,100 | 2,400 | 5.49% |
| Dec 31, 2002 | 43,700 | 2,600 | 6.33% |
| Dec 31, 2001 | 41,100 | 5,400 | 15.13% |
| Dec 31, 2000 | 35,700 | 4,400 | 14.06% |
| Dec 31, 1999 | 31,300 | 1,500 | 5.03% |
| Dec 31, 1998 | 29,800 | -1,300 | -4.18% |
| Dec 31, 1997 | 31,100 | 1,900 | 6.51% |
| Dec 31, 1996 | 29,200 | 2,400 | 8.96% |
| Dec 31, 1995 | 26,800 | 1,900 | 7.63% |
| Dec 31, 1994 | 24,900 | -7,800 | -23.85% |
| Dec 31, 1993 | 32,700 | 500 | 1.55% |
| Dec 31, 1992 | 32,200 | 1,400 | 4.55% |
| Dec 31, 1991 | 30,800 | 1,300 | 4.41% |
| Dec 31, 1990 | 29,500 | 1,700 | 6.12% |
| Dec 31, 1989 | 27,800 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Johnson & Johnson | 138,200 |
| AstraZeneca | 95,100 |
| Novartis AG | 75,267 |
| Merck & Co. | 75,000 |
| Pfizer | 75,000 |
| Sanofi | 74,846 |
| Novo Nordisk | 69,505 |
| AbbVie | 57,000 |
LLY News
- 2 days ago - Lilly stock falls as Foundayo trails Novo's Wegovy in early uptake - Invezz
- 2 days ago - Lilly's obesity pill hits nearly 4000 prescriptions in second week after launch - Reuters
- 4 days ago - Eli Lilly Is More Than GLP-1 Drugs. The Stock Looks Attractive. - Barrons
- 5 days ago - Health insurers raise questions about Medicare program that will offer GLP-1s to seniors for $50 - Market Watch
- 6 days ago - Eli Lilly Goes Atomic—But This Isn't About AI Servers - Benzinga
- 6 days ago - Eli Lilly to acquire Kelonia in $7 billion cancer therapy push - Invezz
- 6 days ago - Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion - CNBC
- 6 days ago - Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies - PRNewsWire